Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel
- PMID: 24393170
- DOI: 10.1111/his.12366
Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel
Abstract
Aims: Owing to their close embryological relationship, soft tissue perineurioma and meningioma may closely mimic each other, not only histologically but also by immunohistochemistry. We aimed to compare the frequency of perineurial marker expression in these two entities, and to determine whether somatostatin receptor 2 (SSTR2) and progesterone receptor (PR), both expressed frequently in meningiomas, are also expressed in perineuriomas.
Methods and results: We analysed and compared the immunohistochemical findings in 58 WHO grade I meningiomas (29 meningothelial, 16 fibrous, 10 transitional, and three others), 10 WHO grade II (atypical) meningiomas, and 20 soft tissue perineuriomas. All tumours were stained using five antibodies against antigens that are known to be expressed in perineuriomas or meningiomas: epithelial membrane antigen (EMA), claudin-1, GLUT-1 (glucose transporter-1), SSTR2, and PR. Of the meningiomas, EMA was expressed in 59 of 61, claudin-1 in five of 63, GLUT-1 in 19 of 62, SSTR2 in 59 of 68, and PR in 44 of 62. Of the perineuriomas, EMA was expressed in 20 of 20, claudin-1 in 17 of 18, GLUT-1 in 14 of 16, SSTR2 in one of 20, and PR in one of 20. The SSTR2-positive/PR-positive phenotype was detected in 42 of 60 meningiomas, but in none of 20 perineuriomas. On the other hand, the claudin-1-positive/GLUT-1-positive phenotype was detected in only four of 62 meningiomas, and in 14 of 16 perineuriomas.
Conclusions: Epithelial membrane antigen expression is ubiquitous in both entities, and does not distinguish between them. SSTR2 and PR are highly sensitive and, in this context, specific meningioma markers. They may be helpful in distinguishing between the two entities, particularly in cases of meningioma occurring at unusual (extracranial) sites.
Keywords: claudin-1; immunohistochemistry; meningioma; perineurioma; progesterone receptor; somatostatin receptor.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma.Hum Pathol. 2009 Nov;40(11):1586-90. doi: 10.1016/j.humpath.2009.04.003. Epub 2009 Jun 21. Hum Pathol. 2009. PMID: 19540561
-
[Extracranial meningioma: morphological and histogenetical aspects and relations with perineurioma].Arkh Patol. 2010 May-Jun;72(3):12-6. Arkh Patol. 2010. PMID: 20734826 Russian.
-
Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics.Am J Surg Pathol. 2002 Dec;26(12):1620-6. doi: 10.1097/00000478-200212000-00010. Am J Surg Pathol. 2002. PMID: 12459629
-
Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparative immunohistochemical study.Am J Surg Pathol. 1989 Apr;13(4):251-61. doi: 10.1097/00000478-198904000-00001. Am J Surg Pathol. 1989. PMID: 2648875 Review.
-
Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases.Am J Surg Pathol. 2005 Jul;29(7):859-65. doi: 10.1097/01.pas.0000154130.87219.2c. Am J Surg Pathol. 2005. PMID: 15958849 Review.
Cited by
-
Intraneural malignant perineurioma: a case report and review of literature.Int J Clin Exp Pathol. 2014 Jun 15;7(7):4503-7. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120842 Free PMC article. Review.
-
Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma.Front Oncol. 2020 Sep 3;10:1633. doi: 10.3389/fonc.2020.01633. eCollection 2020. Front Oncol. 2020. PMID: 33014821 Free PMC article. Review.
-
CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications.Virchows Arch. 2022 Jun;480(6):1223-1230. doi: 10.1007/s00428-022-03304-9. Epub 2022 Feb 25. Virchows Arch. 2022. PMID: 35212813 Free PMC article.
-
Radioligand therapies in meningioma: Evidence and future directions.Neuro Oncol. 2024 Dec 9;26(Supplement_9):S215-S228. doi: 10.1093/neuonc/noae069. Neuro Oncol. 2024. PMID: 38702966 Free PMC article. Review.
-
Soft tissue perineurioma involving the kidney: a report of two cases with an emphasis on differential diagnosis.Diagn Pathol. 2021 Sep 30;16(1):87. doi: 10.1186/s13000-021-01149-5. Diagn Pathol. 2021. PMID: 34592995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous